Literature DB >> 2892126

Evidence for multiple tachykinin receptor subtypes on the rabbit iris sphincter muscle.

H P Too1, W G Unger, M R Hanley.   

Abstract

The actions of mammalian tachykinins (substance P, substance K/neurokinin a, neuromedin K/neurokinin b) and non-mammalian tachykinins (eledoisin, kassinin, physalaemin) were compared on the rabbit pupillary sphincter. All acted as direct spasmogens with potencies in the order: eledoisin greater than physalaemin = neurokinin b = substance P greater than kassinin greater than neurokinin a. However, their actions could be divided into at least two categories on the basis of similar kinetics of contractions, differential sensitivity to the tachykinin antagonist (D-Arg1, D-Pro2, D-Trp7,9, Leu11) substance P and specific cross-protection against phenoxybenzamine inactivation by structurally related tachykinins. The relationship between these observations and the suggested "P" and "E" subtypes of tachykinin receptors is discussed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2892126

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  4 in total

1.  Solubilization and characterization of substance P-binding sites from chick brain membranes.

Authors:  H P Too; M R Hanley
Journal:  Biochem J       Date:  1988-06-01       Impact factor: 3.857

2.  Classification of tachykinin receptors in muscularis mucosae of opossum oesophagus.

Authors:  E E Daniel; S Cipris; Y Manaka; P Bowker; D Regoli
Journal:  Br J Pharmacol       Date:  1989-08       Impact factor: 8.739

3.  Tachykinin receptors mediating responses to sensory nerve stimulation and exogenous tachykinins and analogues in the rabbit isolated iris sphincter.

Authors:  J M Hall; D Mitchell; I K Morton
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

4.  Typical and atypical NK1 tachykinin receptor characteristics in the rabbit isolated iris sphincter.

Authors:  J M Hall; D Mitchell; I K Morton
Journal:  Br J Pharmacol       Date:  1994-07       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.